Indaptus Therapeutics Inc... (INDP)
0.81
0.02 (3.09%)
At close: Feb 28, 2025, 3:59 PM
0.84
3.76%
After-hours: Feb 28, 2025, 04:00 PM EST
Indaptus Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.28K | 1.78K | 1.4K | 852.00 | 854K | 859K | 829K | 701K | 745.9K | 584.82K | 602.85K | 555.43K | 340.68K | 367.33K | 305.53K | 302.32K |
| Gross Profit | -1.28K | -1.78K | -1.4K | -852 | -854K | -859K | -829K | -701K | -745.9K | -584.82K | -602.85K | -555.43K | -340.68K | -367.33K | -305.53K | -302.32K |
| Operating Income | -16.38M | -14.91M | -7.73M | -3.6M | -34.95M | -43.33M | -29.44M | -13.85M | -7.6M | -7.57M | -5.17M | -5.37M | -7.76M | -5.34M | -3.93M | -4.91M |
| Interest Income | n/a | 588.11K | 17.72K | 15.11K | 330K | 852K | 286K | 176K | 44.78K | 172.48K | 111.37K | 79.87K | 53.94K | 43.94K | 1.02K | 61.69K |
| Pretax Income | -15.42M | -14.32M | -7.71M | -3.58M | -46.96M | -43.44M | -28.88M | -13.36M | -7.18M | -5.69M | -5.09M | -5.18M | -7.58M | -5.42M | -3.94M | -5.36M |
| Net Income | -15.42M | -13.73M | -7.69M | -3.57M | -47.6M | -43.54M | -28.91M | -13.36M | -7.18M | -5.69M | -5.09M | -5.18M | -7.58M | -5.42M | -3.94M | -5.36M |
| Selling & General & Admin | 8.76M | 8.59M | 5.21M | 944.25K | 7.43M | 7.07M | 4.32M | 3.07M | 2.77M | 2.59M | 2.41M | 2.12M | 2.74M | 2.65M | 1.78M | 1.67M |
| Research & Development | 7.62M | 6.32M | 2.52M | 2.66M | 26.66M | 35.4M | 24.3M | 10.07M | 4.09M | 4.39M | 2.16M | 2.69M | 4.69M | 2.32M | 1.84M | 2.94M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 16.38M | 14.91M | 7.73M | 3.6M | 34.09M | 42.47M | 28.61M | 13.14M | 6.85M | 6.98M | 4.56M | 4.81M | 7.42M | 4.97M | 3.62M | 4.61M |
| Interest Expense | n/a | 588.11K | n/a | n/a | 15K | 23K | 17K | 16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 100.74K | n/a | n/a | n/a | 7.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 16.38M | 14.91M | 7.73M | 3.6M | 34.95M | 43.33M | 29.44M | 13.85M | 7.6M | 7.57M | 5.17M | 5.37M | 7.76M | 5.34M | 3.93M | 4.91M |
| Income Tax | n/a | -588.11K | -17.72K | -15.11K | 638K | 103K | 29K | n/a | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 8.4M | 8.26M | 4.09M | 486.17K | 422.2K | 389.91K | 220.75K | 143.1K | 97.39K | 3.02M | 2.68M | 2.42M | 2.14M | 1.71M | 1.11M | 716.52K |
| Shares Outstanding (Diluted) | 8.4M | 8.26M | 4.09M | 486.17K | 422.2K | 389.91K | 220.75K | 143.1K | 97.39K | 3.02M | 2.68M | 2.42M | 2.14M | 1.71M | 1.11M | 716.52K |
| EPS (Basic) | -1.84 | -1.66 | -1.88 | -7.34 | -112.74 | -111.67 | -130.96 | -93.38 | -73.7 | -1.89 | -1.9 | -2.14 | -3.55 | -3.17 | -3.54 | -7.48 |
| EPS (Diluted) | -1.84 | -1.66 | -1.88 | -7.34 | -112.74 | -111.67 | -130.96 | -93.38 | -73.7 | -1.89 | -1.9 | -2.14 | -3.55 | -3.17 | -3.54 | -7.48 |
| EBITDA | -16.38M | -14.91M | -7.73M | -3.6M | -46.09M | -42.56M | -28.61M | -13.14M | -6.43M | -5.11M | -4.49M | -4.63M | -7.24M | -5.06M | -3.64M | -5.06M |
| Depreciation & Amortization | 1.28K | 1.78K | 1.4K | 852.00 | 854K | 859K | 829K | 701K | 745.9K | 584.82K | 602.85K | 555.43K | 340.68K | 367.33K | 305.53K | 302.32K |